Repeat-dose pharmacokinetics and pharmacodynamics of bortezomib in patients with relapsed multiple myeloma
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2011
At a glance
- Drugs Bortezomib (Primary)
- Indications Multiple myeloma
- Focus Pharmacodynamics; Pharmacokinetics
- 08 Feb 2008 Status changed from in progress to completed.
- 23 Aug 2005 New trial record.